“SLC39A1 Contributes to Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma by Activating AMPK Signaling”. Bangladesh Journal of Pharmacology 19, no. 2 (June 15, 2024): 52–58. Accessed June 23, 2026. https://www.banglajol.info/index.php/BJP/article/view/72787.